VIATRIS INC (VTRS) Stock Fundamental Analysis

NASDAQ:VTRS • US92556V1061

14.93 USD
-0.32 (-2.1%)
At close: Feb 27, 2026
14.93 USD
0 (0%)
After Hours: 2/27/2026, 5:20:02 PM
Fundamental Rating

4

Overall VTRS gets a fundamental rating of 4 out of 10. We evaluated VTRS against 192 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of VTRS while its profitability can be described as average. VTRS has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • VTRS had positive earnings in the past year.
  • VTRS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VTRS reported negative net income in multiple years.
  • VTRS had a positive operating cash flow in 4 of the past 5 years.
VTRS Yearly Net Income VS EBIT VS OCF VS FCFVTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • VTRS has a better Return On Assets (-9.73%) than 68.23% of its industry peers.
  • VTRS's Return On Equity of -24.26% is fine compared to the rest of the industry. VTRS outperforms 66.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.41%, VTRS belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
  • VTRS had an Average Return On Invested Capital over the past 3 years of 4.05%. This is significantly below the industry average of 12.96%.
Industry RankSector Rank
ROA -9.73%
ROE -24.26%
ROIC 3.41%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
VTRS Yearly ROA, ROE, ROICVTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • Looking at the Operating Margin, with a value of 9.34%, VTRS belongs to the top of the industry, outperforming 82.29% of the companies in the same industry.
  • VTRS's Operating Margin has declined in the last couple of years.
  • VTRS's Gross Margin of 39.36% is fine compared to the rest of the industry. VTRS outperforms 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of VTRS has remained more or less at the same level.
Industry RankSector Rank
OM 9.34%
PM (TTM) N/A
GM 39.36%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
VTRS Yearly Profit, Operating, Gross MarginsVTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VTRS is destroying value.
  • VTRS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VTRS Yearly Shares OutstandingVTRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VTRS Yearly Total Debt VS Total AssetsVTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • Based on the Altman-Z score of 1.03, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
  • VTRS's Altman-Z score of 1.03 is in line compared to the rest of the industry. VTRS outperforms 55.21% of its industry peers.
  • The Debt to FCF ratio of VTRS is 8.96, which is on the high side as it means it would take VTRS, 8.96 years of fcf income to pay off all of its debts.
  • VTRS has a Debt to FCF ratio of 8.96. This is amongst the best in the industry. VTRS outperforms 81.25% of its industry peers.
  • VTRS has a Debt/Equity ratio of 0.82. This is a neutral value indicating VTRS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.82, VTRS is not doing good in the industry: 70.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.96
Altman-Z 1.03
ROIC/WACC0.42
WACC8.08%
VTRS Yearly LT Debt VS Equity VS FCFVTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • VTRS has a Current Ratio of 1.35. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
  • VTRS has a Current ratio of 1.35. This is in the lower half of the industry: VTRS underperforms 74.48% of its industry peers.
  • A Quick Ratio of 0.79 indicates that VTRS may have some problems paying its short term obligations.
  • VTRS has a Quick ratio of 0.79. This is amonst the worse of the industry: VTRS underperforms 81.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.79
VTRS Yearly Current Assets VS Current LiabilitesVTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

  • The earnings per share for VTRS have decreased strongly by -10.94% in the last year.
  • Measured over the past years, VTRS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.71% on average per year.
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.97%

3.2 Future

  • Based on estimates for the next years, VTRS will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.43% on average per year.
  • The Revenue is expected to grow by 2.36% on average over the next years.
EPS Next Y7.18%
EPS Next 2Y8.21%
EPS Next 3Y8.07%
EPS Next 5Y16.43%
Revenue Next Year1.6%
Revenue Next 2Y1.81%
Revenue Next 3Y1.73%
Revenue Next 5Y2.36%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
VTRS Yearly Revenue VS EstimatesVTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VTRS Yearly EPS VS EstimatesVTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.33, which indicates a rather cheap valuation of VTRS.
  • Compared to the rest of the industry, the Price/Earnings ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 95.31% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.11, VTRS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 5.90, the valuation of VTRS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, VTRS is valued cheaply inside the industry as 94.27% of the companies are valued more expensively.
  • VTRS is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.33
Fwd PE 5.9
VTRS Price Earnings VS Forward Price EarningsVTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VTRS is valued cheaper than 91.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 91.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.67
EV/EBITDA 7.52
VTRS Per share dataVTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y8.21%
EPS Next 3Y8.07%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.67%, VTRS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.07, VTRS pays a better dividend. On top of this VTRS pays more dividend than 95.83% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, VTRS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

  • VTRS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
VTRS Yearly Dividends per shareVTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • The earnings of VTRS are negative and hence is the payout ratio. VTRS will probably not be able to sustain this dividend level.
DP-15.34%
EPS Next 2Y8.21%
EPS Next 3Y8.07%
VTRS Yearly Income VS Free CF VS DividendVTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

VIATRIS INC

NASDAQ:VTRS (2/27/2026, 5:20:02 PM)

After market: 14.93 0 (0%)

14.93

-0.32 (-2.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners86.94%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change0.07%
Market Cap17.20B
Revenue(TTM)N/A
Net Income(TTM)-3.69B
Analysts74.44
Price Target14.17 (-5.09%)
Short Float %2.42%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)2.61%
PT rev (3m)10.4%
EPS NQ rev (1m)-0.41%
EPS NQ rev (3m)-0.27%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE 6.33
Fwd PE 5.9
P/S 1.22
P/FCF 10.67
P/OCF 8.67
P/B 1.13
P/tB N/A
EV/EBITDA 7.52
EPS(TTM)2.36
EY15.81%
EPS(NY)2.53
Fwd EY16.94%
FCF(TTM)1.4
FCFY9.37%
OCF(TTM)1.72
OCFY11.53%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)0.88
PEG (5Y)N/A
Graham Number26.49
Profitability
Industry RankSector Rank
ROA -9.73%
ROE -24.26%
ROCE 4.32%
ROIC 3.41%
ROICexc 3.53%
ROICexgc 14.83%
OM 9.34%
PM (TTM) N/A
GM 39.36%
FCFM 11.41%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.96
Debt/EBITDA 3.05
Cap/Depr 13.37%
Cap/Sales 2.63%
Interest Coverage 250
Cash Conversion 48.4%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.79
Altman-Z 1.03
F-Score4
WACC8.08%
ROIC/WACC0.42
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
EPS Next Y7.18%
EPS Next 2Y8.21%
EPS Next 3Y8.07%
EPS Next 5Y16.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.97%
Revenue Next Year1.6%
Revenue Next 2Y1.81%
Revenue Next 3Y1.73%
Revenue Next 5Y2.36%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-4.89%
EBIT Next 3Y1.44%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%

VIATRIS INC / VTRS FAQ

What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VTRS.


What is the valuation status for VTRS stock?

ChartMill assigns a valuation rating of 8 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.


What is the profitability of VTRS stock?

VIATRIS INC (VTRS) has a profitability rating of 5 / 10.


What is the valuation of VIATRIS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for VIATRIS INC (VTRS) is 6.33 and the Price/Book (PB) ratio is 1.13.


How sustainable is the dividend of VIATRIS INC (VTRS) stock?

The dividend rating of VIATRIS INC (VTRS) is 5 / 10 and the dividend payout ratio is -15.34%.